期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Drug Metabolism and Pharmacokinetics LetPub Score 5.0
50 ratings
Rate
Reputation 5.9 Influence 3.9 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | DRUG METAB PHARMACOK | ||||||||||||||||||||||||
ISSN | 1347-4367 | ||||||||||||||||||||||||
E-ISSN | 1880-0920 | ||||||||||||||||||||||||
h-index | 58 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 7.40%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.jstage.jst.go.jp/browse/dmpk | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/DMPK | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | Japanese Society for the Study of Xenobiotics | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | JAPAN | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 2002 | ||||||||||||||||||||||||
每年文章數 | 40每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 36.49% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1347-4367%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 75% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Drug Metabolism and Pharmacokinetics] 的評論 | 撰寫評論 |
作者: 宫古俊贺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-04 14:34:09 評論於 Do I need to pay for the layout fee?(0) 讚! | 宫古俊贺 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:10:02 評論於 ORCID is an open researcher and contributor ID, and it is a non-profit organization. The ORCID ID is a unique and persistent academic identity for contributors, which distinguishes authors from other researchers and records all related research activities of the author(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 17:01:09 評論於 What is ORCID iD? How do I register?(0) 讚! | 陶宜三岁啦 |
作者: 中原秋波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-11-03 17:27:25 評論於 Drug Metabolism and Pharmacokinetics has been under review for over 40 days with no change in status. Can I ask what is going on?(0) 讚! | 中原秋波 |
作者: 留云曼凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-02-06 15:52:33 評論於 Review speed: 6.0 | Submission hit rate: 50.0 Experience sharing: Share submission experience with everyone for reference. Submitted on September 18, 2015 with editor October 16, under review October 27, changed to under review once more November 11, changed to under review again (speculated to be changing reviewers each time) November 16, under editor evaluation December 3, decision in process December 4, revise December 19, revision submitted to journal December 21, with editor December 22, under review January 13, 2016, decision in process January 15, accept January 18, final accept(0) 讚! | 留云曼凝 |
作者: 克样mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-12-16 22:54:24 評論於 Review Speed: 2.0 | Submission Success Rate: 50.0 Sharing of Experience: At the end of the year, the progress has slowed down, but overall it is good. Here is the submission link for everyone: http://ees.elsevier.com/dmpk/default.asp(0) 讚! | 克样mm |
作者: 极乐玉淇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-12-14 18:50:37 評論於 Please provide the submission link(0) 讚! | 极乐玉淇 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-09-03 16:36:40 評論於 Excuse me, I would like to ask where is the submission system for the journal "Drug Metabolism and Pharmacokinetics"? I couldn't find it online, please advise, thank you!(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-30 18:40:29 評論於 Overall, the performance is relatively optimistic, approaching around 3 points this year, which is significantly higher than last year. It should reach 3 points next year(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-06-27 20:55:22 評論於 Review speed: 1.0 | Submission acceptance rate: 75.0 Experience sharing: The review is quick and relatively easy to accept. Those with limited time can consider it~(0) 讚! | 凌霄高洁 |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2013-04-09 22:05:00 評論於 Journal Homepage URL: https://www.jstage.jst.go.jp/browse/dmpk(0) 讚! | 匿名 |
作者: 百花梓瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-02-13 14:28:44 評論於 Review speed: 1.0 Experience sharing: Review speed is fast, about 20 days. The focus is on drug metabolism and pharmacokinetics. Previously submitted articles on other topics but now seems to only accept articles on drug metabolism and pharmacokinetics. Submitted an article on basic pharmacology and was rejected directly(0) 讚! | 百花梓瑶 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-10-06 18:54:33 評論於 Review Speed: 1.0 | Submission Acceptance Rate: 75.0 Experience Sharing: The review process was fast, and the feedback after revisions was also prompt, within two weeks. It took around two months from submission to acceptance(0) 讚! | 凌霄高洁 |
作者: 白云笑卉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-28 16:57:11 評論於 Research focus: Metabolism(0) 讚! | 白云笑卉 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us